Drug Profile
Research programme: oral DTPA - SRI International
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator SRI International
- Class
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Radiation injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Radiation injuries in USA (PO)
- 23 May 2006 Preclinical trials in Radiation injuries/Radioprotection in USA (PO)